Back to results
US 5,314,906 AGranted
Derivatives of physostigmine, their use and pharmaceutical formulations containing them
AssigneeIndena S.p.A.
InventorEzio Bombardelli
Life of this patent
Estimating the term…
Abstract
The therapeutic use of new salts of physostigmine in the treatment of syndromes related to changes in cerebral metabolism in the elderly is described. The new salts of physostigmine, which are based on phosphatidic acid, are highly lipophilic and exhibit excellent bioavailability when administered orally, transcutaneously or transepidermally.
Claims11
A salt of physostigmine and a phosphatidic acid.
Dependencies are inferred from the claim text.